Director, Office of Public Health Genomics, Centers for Disease Control
Best Buy Theater, Northrop Auditorium
View Video Duration: 1 hour 28 minutes
Fulfilling the promise of genomics in improving health requires a population perspective to complement the “bench to bedside” model of clinical translation. An expanded multidisciplinary research agenda is needed to understand the benefits, costs, and harms of genomics in health care and disease prevention (beyond bench to bedside) in the larger context of social and environmental determinants of disease.
Direct Providership
The University of Minnesota is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Minnesota designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals Statement
Other Healthcare Professionals who participate in this CPD activity may submit their Statements of Participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.
Muin Khoury, MD, PhD is the founding director of CDC's Office of Public Health Genomics. The Office was formed in 1997 to assess the impact of advances in human genetics on public health and disease prevention. He received his medical degree and pediatrics training from the American University of Beirut, Lebanon, and a PhD in human genetics/genetic epidemiology from Johns Hopkins.
Dr. Khoury also serves as Acting Associate Director, Epidemiology and Genomics Research Program (EGRP), in the National Cancer Institute's (NCI) Division of Cancer Control and Population Sciences (DCCPS). Since 2007, he has helped integrate public health genomics research into the Division's research portfolio, such as comparative effectiveness research in genomics and personalized medicine. Dr. Khoury is an adjunct professor of Epidemiology at Emory's School of Public Health, where he originated this course in 1997. His most recent book, Human Genome Epidemiology—the 2nd edition appeared in 2010—covers many of the concepts he will discuss in this lecture.
Commentator:
Dr. Douglas Yee, MD
Director, Masonic Cancer Center
University of Minnesota